Specialty Enzymes

Published by: Global Industry Analysts

Published: Apr. 1, 2008 - 280 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions And Scope Of Study

Specialty Medical Enzymes

Polymerases

Nucleases

Other Specialty Enzymes

Pharmaceuticals/Diagnostic

Research/Biotechnology

II. EXECUTIVE SUMMARY

1. Introduction

Introduction

2. Global Market Overview

Global Market Overview

3. Enzymes- A Review

Definition

Introduction

Advantages of Enzymes Compared to Chemical Catalysts

Table 1: Enzymes Market Worldwide (2005 & 2006): Market Share of Leading Players- Novozymes, Genencol, DSM, BASF and Others (includes corresponding Graph/Chart)

A Brief History

4. Specialty Enzymes: An Overview

Analysis of Product Segments

Specialty Medical Enzymes

Polymerases

Nucleases

Other Specialty Enzymes

5. Analysis of the End-Use Markets

Pharmaceuticals & Diagnostics

Research/Biotechnology

Other End Use Markets

6. Technology Trends

Protein Engineering Technology

Specialty Enzymes in Industrial Uses

Enzyme Technology in Pig Industry

7. Product Innovations/Introductions

MARDI Develops Taq DNA Polymerase

Stratagene Corporation Commercializes DNA Polymerases

Takara Bio Launches PrimeSTAR HS DNA Polymerase

Verdia and Pioneer Hi-Bred International Develops Glyphosate-Resistant Crop Trait

Novozymes Creates Lipase Enzyme

8. Recent Industry Activity

Inverness Medical Innovations Acquires BBI Holdings Plc

Helix Biopharma Enters into a Contract with KBI Biopharma

Verenium Enters into Agreement with Bunge Oils

BBI Holdings Acquires Theratase Plc

Danisco to Acquire Stake in South African Firm

Affymetrix to Buy USB Corporation

Diversa Merges with Celunol to Form Verenium Corporation

Diversa Collaborates with BASF

Codexis Expands Collaboration with Royal Dutch Shell to Develop Super Enzymes

Diversa Enters into a Deal with Syngenta to Develop Enzymes

Genencor Begins Operation at New China Site and Introduces a New Detergent Enzyme

Verenium Receives $4.6 million For Enzyme Development

Biocon Divests its Enzymes Business to Novozymes

Solexa Signs Agreement with New England Biolabs

Danisco Takes Over Genencor

IBEX Technologies Inks Agreement with Cape Cod and Prozyme

9. Focus on Select Players Worldwide

Advanced Enzymes Technologies Limited (India)

Amano Enzyme Inc. (Japan)

Aureozyme Inc. (USA)

Biocon Ltd. (India)

Operational Model of Biocon

Biozyme Laboratories (UK)

Danisco (Denmark)

Genencor (USA)

Kinetic Biosystems, Inc. (USA)

Maxygen Inc (USA)

Codexis Inc. (USA)

Novozymes (Denmark)

Seravac Biotech (Pty) Ltd (South Africa)

Specialty Enzymes and Biochemicals Co. (USA)

Verenium Corporation (USA)

10. Global Market Perspective

Table 2: World Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 3: World Long-term Projections for Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 4: World 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 5: World Recent Past, Current & Future Analysis for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 6: World Long-term Projections for Specialty Medical Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 7: World 10-Year Perspective for Specialty Medical Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 8: World Recent Past, Current & Future Analysis for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 9: World Long-term Projections for Polymerases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 10: World 10-Year Perspective for Polymerases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 11: World Recent Past, Current & Future Analysis for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 12: World Long-term Projections for Nucleases by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 13: World 10-Year Perspective for Nucleases by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 14: World Recent Past, Current & Future Analysis for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 15: World Long-term Projections for Other Specialty Enzymes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 16: World 10-Year Perspective for Other Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 17: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 18: World Long-term Projections for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 19: World 10-Year Perspective for Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 20: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 21: World Long-term Projections for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 22: World 10-Year Perspective for Specialty Enzymes Consumption in Research/Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 23: World Recent Past, Current & Future Analysis for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 24: World Long-term Projections for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 25: World 10-Year Perspective for Specialty Enzymes Consumption in Other End-Use Segments by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

III. MARKET

1. The United States

A. Market Analysis

Market Dynamics

Specialty Enzymes Market is Projected to Rise 7% Annually

Specialty Enzymes Form the Leading Enzymes Segment

Pharmaceuticals and Diagnostics Continue to be the Largest Market

Specialty Medical Enzymes in a Myriad of Novel Applications

Market for Enzymes in Biotechnology

Product Launch

Strategic Corporate Developments

Select Players

Aureozyme Inc

Genencor

Kinetic Biosystems, Inc

Maxygen Inc

Codexis Inc

Specialty Enzymes and Biochemicals Co

Verenium Corporation

B. Market Analytics

Table 26: US Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 27: US Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 28: US 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 29: US Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 30: US Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 31: US 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

2. Canada

A. Market Analysis

Strategic Corporate Development

B. Market Analytics

Table 32: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 33: Canadian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 34: Canadian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 35: Canadian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 36: Canadian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 37: Canadian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

3. Japan

A. Market Analysis

Product Launch

Amano Enzyme Inc. - A Major Player

B. Market Analytics

Table 38: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 39: Japanese Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 40: Japanese 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 41: Japanese Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 42: Japanese Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 43: Japanese 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4. Europe

Market Analysis

Table 44: European Recent Past, Current & Future Analysis for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 45: European Long-term Projections for Specialty Enzymes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 46: European 10-Year Perspective for Specialty Enzymes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 47: European Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 48: European Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 49: European 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 50: European Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 51: European Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 52: European 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4a. France

Market Analysis

Table 53: French Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 54: French Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 55: French 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 56: French Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 57: French Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 58: French 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4b. Germany

Market Analysis

Table 59: German Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 60: German Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 61: German 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 62: German Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 63: German Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 64: German 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4c. Italy

Market Analysis

Table 65: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 66: Italian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 67: Italian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 68: Italian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 69: Italian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 70: Italian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4d. The United Kingdom

A. Market Analysis

Biozyme Laboratories Limited - A Major Player

B. Market Analytics

Table 71: UK Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 72: UK Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 73: UK 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 74: UK Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 75: UK Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 76: UK 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4e. Spain

Market Analysis

Table 77: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 78: Spanish Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 79: Spanish 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012(includes corresponding Graph/Chart)

Table 80: Spanish Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 81: Spanish Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 82: Spanish 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4f. Russia

Market Analysis

Table 83: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 84: Russian Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 85: Russian 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 86: Russian Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 87: Russian Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 88: Russian 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

4g. Rest of Europe

A. Market Analysis

Strategic Corporate Development

Select Players

Danisco (Denmark)

Novozymes (Denmark)

B. Market Analytics

Table 89: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 90: Rest of Europe Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 91: Rest of Europe 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 92: Rest of Europe Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 93: Rest of Europe Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 94: Rest of Europe 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

5. Asia-Pacific

A. Market Analysis

Enzyme Market in China

Product Launch

Strategic Corporate Development

Select Players

Advanced Enzymes Technologies Limited (India)

Biocon Ltd. (India)

B. Market Analytics

Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 96: Asia-Pacific Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 97: Asia-Pacific 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 99: Asia-Pacific Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research / Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 100: Asia-Pacific 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

6. The Middle East

Market Analysis

Table 101: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 102: Middle East Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 103: Middle East 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 104: Middle East Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 105: Middle East Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 106: Middle East 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

7. Latin America

Market Analysis

Table 107: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 108: Latin American Long-term Projections for Specialty Enzymes by Product Segment - Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 109: Latin American 10-Year Perspective for Specialty Enzymes by Product Segment - Percentage Breakdown of Dollar Sales for Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

Table 110: Latin American Recent Past, Current & Future Analysis for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 111: Latin American Long-term Projections for Specialty Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics, Research/Biotechnology and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 112: Latin American 10-Year Perspective for Specialty Enzymes by End-Use Segment - Percentage Breakdown of Dollar Sales for Pharmaceuticals & Diagnostics, Research/ Biotechnology and Others Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.